Evidence map›Paper›PMID 33884250›Full record

ArticleCureus2021

Raynaud's Phenomenon: Beware of Cancers!

Zahida Aqodad, Houda Bachir, Habiba Alaoui, Siham Hamaz, Khalid Serraj

Abstract readCase Reports
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zahida Aqodadinternal Medicine and Immunohematology Cellular Therapy, Faculty of Medicine and Pharmacy, Mohamed First University, Oujda, MAR.
Houda BachirImmunohematology Cellular Therapy, Faculty of Medicine and Pharmacy, Mohamed First University, Oujda, MAR.
Habiba Alaouiimmunohematology Cellular Therapy, Faculty of Medicine and Pharmacy, Mohamed First University, Oujda, MAR.
Siham HamazInfectious Diseases, Faculty of Medicine and Pharmacy, Mohamed First University, Oujda, MAR.
Khalid SerrajInternal Medicine, Faculty of Medicine and Pharmacy, Mohamed First University, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raynaud's phenomenon (RP) is a frequent syndrome and often indicative of connectivitis or hemopathy. The association with solid cancers is exceptional. We report the observation of a patient hospitalized for severe RP whose etiological assessment revealed the existence of colorectal cancer. We discuss, through this clinical case, the potential physiopathological links and underline the importance of looking for underlying cancer in the face of severe, refractory to treatment, or atypical RP.

Indexed as

cancerpathophysiologyraynaud's phenomenon

Identifiers

PMID33884250
PMCPMC8054313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.